572 related articles for article (PubMed ID: 30929309)
1. Nrf2 in cancers: A double-edged sword.
Wu S; Lu H; Bai Y
Cancer Med; 2019 May; 8(5):2252-2267. PubMed ID: 30929309
[TBL] [Abstract][Full Text] [Related]
2. The Role of NRF2/KEAP1 Signaling Pathway in Cancer Metabolism.
Song MY; Lee DY; Chun KS; Kim EH
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922165
[TBL] [Abstract][Full Text] [Related]
3. Role of the Keap1-Nrf2 pathway in cancer.
Leinonen HM; Kansanen E; Pölönen P; Heinäniemi M; Levonen AL
Adv Cancer Res; 2014; 122():281-320. PubMed ID: 24974185
[TBL] [Abstract][Full Text] [Related]
4. The NRF2/KEAP1 Axis in the Regulation of Tumor Metabolism: Mechanisms and Therapeutic Perspectives.
Panieri E; Telkoparan-Akillilar P; Suzen S; Saso L
Biomolecules; 2020 May; 10(5):. PubMed ID: 32443774
[TBL] [Abstract][Full Text] [Related]
5. Contradictory roles of Nrf2/Keap1 signaling pathway in cancer prevention/promotion and chemoresistance.
Jeddi F; Soozangar N; Sadeghi MR; Somi MH; Samadi N
DNA Repair (Amst); 2017 Jun; 54():13-21. PubMed ID: 28415030
[TBL] [Abstract][Full Text] [Related]
6. "NRF2 addiction" in lung cancer cells and its impact on cancer therapy.
Hammad A; Namani A; Elshaer M; Wang XJ; Tang X
Cancer Lett; 2019 Dec; 467():40-49. PubMed ID: 31574294
[TBL] [Abstract][Full Text] [Related]
7. Oxidative Stress and Cancer: The Role of Nrf2.
Sajadimajd S; Khazaei M
Curr Cancer Drug Targets; 2018; 18(6):538-557. PubMed ID: 28969555
[TBL] [Abstract][Full Text] [Related]
8. The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer.
Kansanen E; Kuosmanen SM; Leinonen H; Levonen AL
Redox Biol; 2013 Jan; 1(1):45-9. PubMed ID: 24024136
[TBL] [Abstract][Full Text] [Related]
9. Cancer Cell Growth Is Differentially Affected by Constitutive Activation of NRF2 by KEAP1 Deletion and Pharmacological Activation of NRF2 by the Synthetic Triterpenoid, RTA 405.
Probst BL; McCauley L; Trevino I; Wigley WC; Ferguson DA
PLoS One; 2015; 10(8):e0135257. PubMed ID: 26301506
[TBL] [Abstract][Full Text] [Related]
10. Modulation of NRF2 signaling pathway by nuclear receptors: implications for cancer.
Namani A; Li Y; Wang XJ; Tang X
Biochim Biophys Acta; 2014 Sep; 1843(9):1875-85. PubMed ID: 24851839
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms and systemic targeting of NRF2 dysregulation in cancer.
Kang JS; Nam LB; Yoo OK; Keum YS
Biochem Pharmacol; 2020 Jul; 177():114002. PubMed ID: 32360363
[TBL] [Abstract][Full Text] [Related]
12. NRF2 addiction in cancer cells.
Kitamura H; Motohashi H
Cancer Sci; 2018 Apr; 109(4):900-911. PubMed ID: 29450944
[TBL] [Abstract][Full Text] [Related]
13. Emerging role of NRF2 in chemoresistance by regulating drug-metabolizing enzymes and efflux transporters.
Bai X; Chen Y; Hou X; Huang M; Jin J
Drug Metab Rev; 2016 Nov; 48(4):541-567. PubMed ID: 27320238
[TBL] [Abstract][Full Text] [Related]
14. The Keap1-Nrf2 system as an in vivo sensor for electrophiles.
Uruno A; Motohashi H
Nitric Oxide; 2011 Aug; 25(2):153-60. PubMed ID: 21385624
[TBL] [Abstract][Full Text] [Related]
15. Potential Applications of NRF2 Modulators in Cancer Therapy.
Panieri E; Buha A; Telkoparan-Akillilar P; Cevik D; Kouretas D; Veskoukis A; Skaperda Z; Tsatsakis A; Wallace D; Suzen S; Saso L
Antioxidants (Basel); 2020 Feb; 9(3):. PubMed ID: 32106613
[TBL] [Abstract][Full Text] [Related]
16. The discovery and characterization of K-563, a novel inhibitor of the Keap1/Nrf2 pathway produced by Streptomyces sp.
Hori R; Yamaguchi K; Sato H; Watanabe M; Tsutsumi K; Iwamoto S; Abe M; Onodera H; Nakamura S; Nakai R
Cancer Med; 2019 Mar; 8(3):1157-1168. PubMed ID: 30735010
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers.
Yamadori T; Ishii Y; Homma S; Morishima Y; Kurishima K; Itoh K; Yamamoto M; Minami Y; Noguchi M; Hizawa N
Oncogene; 2012 Nov; 31(45):4768-77. PubMed ID: 22249257
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of the Keap1–Nrf2 pathway in stress response and cancer evolution.
Taguchi K; Motohashi H; Yamamoto M
Genes Cells; 2011 Feb; 16(2):123-40. PubMed ID: 21251164
[TBL] [Abstract][Full Text] [Related]
19. FoxO3 inactivation promotes human cholangiocarcinoma tumorigenesis and chemoresistance through Keap1-Nrf2 signaling.
Guan L; Zhang L; Gong Z; Hou X; Xu Y; Feng X; Wang H; You H
Hepatology; 2016 Jun; 63(6):1914-27. PubMed ID: 26857210
[TBL] [Abstract][Full Text] [Related]
20. Review of molecular mechanisms involved in the activation of the Nrf2-ARE signaling pathway by chemopreventive agents.
Giudice A; Arra C; Turco MC
Methods Mol Biol; 2010; 647():37-74. PubMed ID: 20694660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]